Antibody–Drug Conjugates: A Start of a New Era in Gynecological Cancers

Antibody–Drug Conjugates: A Start of a New Era in Gynecological Cancers

Antibody–drug conjugates (ADCs) are a new class of therapeutic agents designed to target specific antigens on tumor cells, combining the specificity of monoclonal antibodies with the cytotoxicity of chemotherapy agents. ADCs have been available for over a decade, but in gynecological cancers, these...

Full description

Saved in:
Bibliographic Details
Main Authors: Samir Fasih, Stephen Welch, Ana Elisa Lohmann
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Current Oncology
Subjects:
antibody drug conjugates
gynecological cancers
ovarian cancer
cervical cancer
Online Access:https://www.mdpi.com/1718-7729/31/11/522
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items